Services for the Preclinical Development of Therapeutic Agents

NIH RePORTER · NIH · N01 · $481,746 · view on reporter.nih.gov ↗

Abstract

The Services for the Preclinical Development of Therapeutic Agents contract offers a collection of preclinical services to support the development of promising therapeutic candidates, including those for lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; and pre-clinical development planning and evaluation.

Key facts

NIH application ID
10550990
Project number
N01AI60011-P00016-9999-2
Recipient
SRI INTERNATIONAL
Principal Investigator
Jon Carl Mirsalis
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$481,746
Award type
Project period
2006-09-15 → 2012-09-06